Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Graziella Pellegrini

Graziella Pellegrini

individual
Ecosystem influencer

About

Graziella Pellegrini is an Italian cell biologist and regenerative-medicine researcher associated with the University of Modena and Reggio Emilia, where she serves in cell-therapy leadership roles. She co-founded Holostem Terapie Avanzate and helped lead the development of Holoclar, described by EuroStemCell as the first stem cell-based medicinal product approved in Europe. She also holds ecosystem-level influence through scientific and governance roles including ISSCR leadership and Mogrify's Scientific Advisory Board.

Areas of interest

regenerative medicinestem cell biologycell therapygene therapyophthalmologydermatologytranslational medicinerare diseases